|
WO2012100346A1
|
|
Antibodies selective for cells presenting egfr at high density
|
|
WO2012075581A1
|
|
Antibodies selective for cells presenting erbb2 at high density
|
|
WO2005120552A1
|
|
METHODS AND FORMULATIONS OF GnRH/LEUKOTOXIN CHIMERAS FOR TESTOSTERONE SUPPRESSION
|
|
EP1689364A1
|
|
Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents
|
|
AU2004316339A1
|
|
Opioid delivery system
|
|
US2005084523A1
|
|
Opioid delivery system
|
|
CA2467769A1
|
|
Methods and formulations for testosterone suppression
|
|
AU2004216550A1
|
|
Opioid delivery system
|
|
US7648981B2
|
|
Opioid delivery system
|
|
IL161683D0
|
|
Use of n,n-diethyl-2-[4-(phenylmethyl)-phenoxy] ethanamine monohydrochloride (dppe) in cancer therapy
|
|
CA2473024A1
|
|
Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy
|
